Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2ghm | LIC | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.549 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.515 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.500 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.493 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.489 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.488 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.480 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.477 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.474 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.473 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.472 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.469 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.465 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.465 | |
| 3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.464 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.463 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.462 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.461 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.461 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4gyi | ADP | Uncharacterized protein | / | 0.459 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.459 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.458 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 2buj | STU | Serine/threonine-protein kinase 16 | / | 0.456 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 1sn5 | T3 | Transthyretin | / | 0.455 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 3crl | ANP | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.455 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.455 | |
| 4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.455 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.454 | |
| 4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.453 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 1ict | T44 | Transthyretin | / | 0.452 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
| 3w0p | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.452 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.451 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.451 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.450 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.450 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.450 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.450 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.449 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.448 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
| 2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
| 2ev9 | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.446 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 4jrn | ANP | Rhoptry kinase family protein | / | 0.446 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.445 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.445 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.445 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.445 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.444 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.444 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 1eup | ASD | 6-deoxyerythronolide B hydroxylase | / | 0.443 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.443 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.443 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.443 | |
| 3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.442 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.442 | |
| 1ie4 | T44 | Transthyretin | / | 0.441 | |
| 1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.441 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.441 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.441 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.441 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.440 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3zc3 | NAP | Ferredoxin--NADP reductase | 1.18.1.2 | 0.440 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.440 | |
| 4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 |